Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap13.04B
Enterprise Value13.02B
P/E Ratio27.35
PEG Ratio-0.43
Price/Sales Ratio3.59
Price/Book Ratio1.39
Enterprise/Revenue3.69
Enterprise/EBITDA17.3

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.14
Operating Margin0.17
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.04

Income Statement

Revenue2.63B
Revenue/Share2.26
Gross Profit1.09B
EBITDA660.62M
Net Income419.27M
Diluted EPS0.44

Balance Sheet

Total Cash699.24M
Total Cash/Share0.61
Total Debt711.96M
Total Debt/Equity0.09
Current Ratio3.37
Book Value Per Share7.06

Price History

52-Week Change-46.43
52-Week High19.13
52-Week Low9.51
Moving Average 50 Days12.02
Moving Average 200 Days14.02

Statistics

Average Volume11.9M
Shares Outstanding950.4M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.38
Trailing Annual Dividend Yield3.92
Payout Ratio0.76
Last Split Factor1952679:1000000
Last Split DateJuly 27, 2020
AD